Skip to Main Content

Paper Details

Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer.
Eur Urol Focus
8
2022
Metastatic Prostate Cancer, Patients, men, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, patients
Author NameAffiliation
Piet OstGhent University
Johan LindbergKarolinska Institutet
Henrik Gr??nbergKarolinska Institutet
Henrik Gr??nbergKarolinska Institutet
  • 1 - 4

Datasets

Release 1.2